홈
CB

Chengdu Baiyu Pharmaceuticals Co., Ltd

318
13
5
4.9(17)

회사 소개

  • 법인명: Chengdu Baiyu Pharmaceuticals Co., Ltd
  • 국제 명칭: 成都百裕制药股份有限公司 (Chengdu Baiyu Pharmaceutical Co., Ltd.), Chengdu, Sichuan, China
  • 브랜드명 / 상호: Baiyu
  • 등록 국가: China
  • 주소: SichuanChengduChengdu National Cross-Straits Science and Technology Industrial Development Park, Wenjiang District, Chengdu • Sichuan
설명:

Chengdu Baiyu Pharmaceuticals Co., Ltd, formally established in 2005 (its predecessor began ginkgolide R&D in 2002) and based in the Chengdu National Cross-Straits Science and Technology Industrial Development Park in Wenjiang District, manufactures active pharmaceutical ingredients and finished dosage forms spanning cardiovascular, macrolide and antipyretic/analgesic categories, with ginkgolide as a signature product line. Its ginkgolide injection was approved in 2011, and its ginkgolide dropping pills progressed through Phase I (2017), Phase II (2019) and Phase III (2023) clinical trials; its freeze-dried powder injection workshop passed EU GMP certification in 2022, and in 2024 the company signed an exclusive global licensing agreement with Novartis for a small-molecule drug in development. The company holds 335 China and overseas patent applications (105 granted) and two new-drug certificates, and its ginkgo-related patent won the 18th China Patent Excellence Award. Offering CRO, CSO and CDMO contract services, with roughly 90% domestic and 10% export sales shipped FOB or CIF and settled via L/C or T/T, the company is recognized for its brand, international certification, experienced R&D personnel and broad product line.

사업 활동

천연추출물 & 생약원료

제조업체

계약 및 아웃소싱 서비스

위탁개발생산기관 (CDMO)

제약용 화학물질

제조업체서비스 제공업체수출업체

원료의약품(API)

서비스 제공업체제조업체수출업체

완제 의약품

수출업체서비스 제공업체제조업체

당사 제품 & 서비스

인증

GMP certification in China

GMP inspection and obtaining the EU GMP certificate

필터:
정렬:

    댓글이 없습니다.